目錄:MedChemExpress LLC>>生化試劑>> DDO-5936 | MCE
CAS | 2355377-13-6 | 分子量 | 495.59 |
---|---|---|---|
分子式 | C??H??N?O?S | 供貨周期 | 現(xiàn)貨 |
規(guī)格 | 5 mg | 貨號 | HY-139301 |
應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務(wù)。
CAS No. : 2355377-13-6
產(chǎn)品活性:DDO-5936 is a potent and specific Hsp90-Cdc37 PPI inhibitor. DDO-5936 can be used for the research of colorectal cancer.
研究領(lǐng)域:Cell Cycle/DNA Damage | Metabolic Enzyme/Protease
作用靶點:HSP
In Vitro: DDO-5936 is a Hsp90-Cdc37 PPI inhibitor with potency and specificity through binding to a critical site on Hsp90 involving Glu47.
In Vivo: DDO-5936 (0~80 mg/kg; p.o.) shows effect at the high dose group.
DDO-5936 is well tolerated for the absence of serious weight loss. DDO-5936 high dose groups show that tumor cells in the xenografts decreased significantly. DDO-5936 shows limited oral efficiency.
相關(guān)產(chǎn)品:Bioactive Compound Library Plus | Cell Cycle/DNA Damage Compound Library | Metabolism/Protease Compound Library | Anti-Cancer Compound Library | Anti-Aging Compound Library | Cytoskeleton Compound Library | Anti-Colorectal Cancer Compound Library | Protein-protein Interaction Inhibitor Library | Anti-Prostate Cancer Compound Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | Hsp90-IN-17 | Palmitic acid | HSP90-IN-18 | Paeoniflorin | Pimitespib | Debio 0932 | KU-177 | AMP-PCP disodium | Tamoxifen | JG-231 | MPC-0767 | HDAC6/HSP90-IN-1 | Retaspimycin | Onalespib | HM03 | EC144 | 2-Hexyl-4-pentynoic acid | Cucurbitacin D | NCT-58 | MKT-077 | Cemdomespib | 6BrCaQ-C10-TPP | Rocaglamide | Novobiocin | Aminohexylgeldanamycin hydrochloride | Gedunin | KBU2046 | HSF1A
熱門產(chǎn)品線:重組蛋白 | 化合物庫 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標記物 | 寡核苷酸 | 抗體 | 點擊化學(xué)
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,我們致力于為*科研客戶提供前沿的高品質(zhì)小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領(lǐng);
• 產(chǎn)品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產(chǎn)品,廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項目;
• 提供虛擬篩選,離子通道篩選,代謝組學(xué)分析檢測分析,藥物篩選等專業(yè)技術(shù)服務(wù);
• 設(shè)有專業(yè)的實驗中心和嚴格的質(zhì)控、驗證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質(zhì)檢報告,確保產(chǎn)品的高純度、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業(yè)團隊跟蹤最新的制藥及生命科學(xué)研究進展,為您提供*新的活性化合物;
• 與世界各大制藥公司及著名科研機構(gòu)建立了長期的合作。